Avastin®

Random entry RSS

Posted in:
Legal

Complaint in Genentech v. Amgen Dismissed Without Prejudice
By Daniel McCallum and C. Nichole Gifford March 2, 2017 Comments are off
Genentech’s lawsuit against Amgen has come to a quick (although perhaps temporary) end, with the Court dismissing Genentech’s complaint...

Read more

Tagged with: Amgen, Avastin®, bevacizumab, BPCIA, District Court, Genentech, Genentech v. Amgen, Legal, Litigation, Patent Dance

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:
Legal

Genentech Sues Amgen Over BPCIA Disclosures for Avastin® (bevacizumab)
By C. Nichole Gifford February 20, 2017 Comments are off
On February 15, 2017, Genentech filed litigation accusing Amgen of violating the Biologics Price Competition and Innovation Act...

Read more

Tagged with: Avastin®, bevacizumab, BPCIA, District Court, Genentech v. Amgen, Legal, Litigation, Patent Dance

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top